Neoadjuvant chemoimmunotherapy in early triple-negative breast cancer: a new kid on the block?

被引:1
|
作者
Rizzo, Alessandro [1 ]
Palmiotti, Gennaro [1 ]
机构
[1] IRCCS Ist Tumori Giovanni Paolo II, Struttura Semplice Dipartimentale Oncol Med, Presa Carico Globale Paziente Oncol Don Toni, Viale Orazio Flacco 65, I-70124 Bari, Italy
关键词
atezolizumab; breast cancer; immune checkpoint inhibitors; immunotherapy; pembrolizumab; triple-negative breast cancer; IMMUNOTHERAPY;
D O I
10.2217/imt-2022-0021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:755 / 758
页数:4
相关论文
共 50 条
  • [31] Neoadjuvant eribulin in early triple negative breast cancer
    Naito, Y.
    Yonemori, K.
    Yamamoto, H.
    Takahashi, M.
    Nakamura, R.
    Masuda, N.
    Aogi, K.
    Yamanaka, T.
    Ito, Y.
    Yoshida, A.
    Tsuda, H.
    Kuchiba, A.
    Hata, T.
    Tamura, K.
    Fujiwara, Y.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S97 - S98
  • [32] New Approaches for Triple-Negative Breast Cancer
    不详
    ONCOLOGY-NEW YORK, 2012, 26 (10): : 916 - +
  • [33] New targets in triple-negative breast cancer
    Robert L. Copeland
    Yasmine Kanaan
    Nature Reviews Cancer, 2021, 21 : 744 - 744
  • [34] New targets in triple-negative breast cancer
    Copeland, Robert L.
    Kanaan, Yasmine
    NATURE REVIEWS CANCER, 2021, 21 (12) : 744 - 744
  • [35] New Targets for Triple-Negative Breast Cancer
    Herold, Christina I.
    Anders, Carey K.
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 846 - 854
  • [36] Extent of Breast Surgery After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Ponzone, Riccardo
    Montemurro, Filippo
    JAMA SURGERY, 2020, 155 (08) : 785 - 786
  • [37] Pembrolizumab in Early Triple-Negative Breast Cancer Reply
    Schmid, Peter
    Cortes, Javier
    Dent, Rebecca
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (18): : 1771 - 1772
  • [38] Pembrolizumab for Early Triple-Negative Breast Cancer Reply
    Schmid, Peter
    Dent, Rebecca
    O'Shaughnessy, Joyce
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (26):
  • [39] Advances in the Treatment of Triple-negative Early Breast Cancer
    Basso, Stefano M. M.
    Santeufemia, Davide A.
    Fadda, Giovanni M.
    Tozzoli, Renato
    D'Aurizio, Federica
    Lumachi, Franco
    MEDICINAL CHEMISTRY, 2016, 12 (03) : 268 - 272
  • [40] Costs per event averted in the neoadjuvant and adjuvant settings of early triple-negative breast cancer
    Olivier, T.
    Prasad, V.
    ANNALS OF ONCOLOGY, 2023, 34 (08) : 723 - 724